DocGo Inc
NASDAQ:DCGO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.84
5.61
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
DCGO Price Targets Summary
DocGo Inc
According to Wall Street analysts, the average 1-year price target for DCGO is 6.3386 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
DCGO Last Price Targets
DocGo Inc
The latest public price target was made on May 9, 2024 by
Richard Close
from
Canaccord Genuity
,
who expects
DCGO
stock to
rise by 16%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Richard Close
Canaccord Genuity
|
5
USD
Upside 16% |
7 months ago
May 9, 2024
|
DocGo (DCGO) PT Lowered to $5 at Canaccord Genuity
StreetInsider
|
David Grossman
Stifel Nicolaus
|
8
USD
Upside 86% |
8 months ago
Apr 10, 2024
|
DocGo (DCGO) PT Lowered to $8 at Stifel
StreetInsider
|
|
David Larsen
BTIG
|
11
USD
Upside 156% |
8 months ago
Apr 10, 2024
|
DocGo (DCGO) PT Lowered to $11 at BTIG
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DCGO's stock price target?
Price Target
6.3386
USD
According to Wall Street analysts, the average 1-year price target for DCGO is 6.3386 USD with a low forecast of 5.05 USD and a high forecast of 8.4 USD.
What is DocGo Inc's Revenue forecast?
Projected CAGR
-9%
For the last 2 years the compound annual growth rate for DocGo Inc's revenue is 40%. The projected CAGR for the next 3 years is -9%.
What is DocGo Inc's Operating Income forecast?
Projected CAGR
14%
For the last 2 years the compound annual growth rate for DocGo Inc's operating income is -11%. The projected CAGR for the next 3 years is 14%.
What is DocGo Inc's Net Income forecast?
Projected CAGR
38%
For the last 2 years the compound annual growth rate for DocGo Inc's net income is -46%. The projected CAGR for the next 3 years is 38%.
You don't have any saved screeners yet
